home / stock / odyy / odyy news

ODYY News and Press, Odyssey Group International Inc From 05/05/22

Stock Information
Company Name: Odyssey Group International Inc
Stock Symbol: ODYY
Market: OTC
Website: odysseygi.com
Menu
ODYY ODYY Quote ODYY Short ODYY News ODYY Articles ODYY Message Board
Get ODYY Alerts

News, Short Squeeze, Breakout and More Instantly...
ODYY - Odyssey Health, Inc. Announces Positive Results from Initial Phase I Clinical Trial Subjects for Concussion Drug

Irvine, CA, May 05, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC Pink: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-saving medical products, today announced positive results from the first group of patients dosed with PRV-002, in their P...
ODYY - Odyssey Health Welcomes United States Vice Admiral (r) Timothy Szymanski to Military Advisory Board

Irvine, CA, April 20, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc., formerly known as Odyssey Group International, Inc. (OTC Pink: ODYY) (the "Company" or "Odyssey"), a company focused on developing a proprietary drug compound to treat concussion, is honored to welcome Vice Admiral (r) Tim...

ODYY - Odyssey Group International Announces Formation of Military Advisory Board and Welcomes Prestigious Members to Assist with Concussion Drug Development

Irvine, CA, March 31, 2022 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC Pink: ODYY) (the "Company" or "Odyssey"), a company focused on developing unique, life-saving medical products, today announced the formation of its Military Advisory Board with the appointment of prestigi...

ODYY - NFL LEGEND BRETT FAVRE AND ODYSSEY HEALTH, INC. INVOLVED WITH HUMAN TRIALS OF FIRST DRUG TREATMENT FOR CONCUSSION

IRVINE, CA, Feb. 11, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. f/k/a Odyssey Group International, Inc. (OTC Pink: ODYY) today announced the continued enrollment of its first in kind human clinical trial of its proprietary drug compound intended to treat concussion. NFL Hall of Fame ...
ODYY - Odyssey Group International Receives Donation to Support a Treatment for Concussion and forms Community Partnership with the Erase PTSD Now Foundation

IRVINE, CA, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC Pink: ODYY) (the "Company" or "Odyssey"), a company focused on developing unique, life-saving medical products, today announced that it has received a donation in the amount of $500,000 in partnership with ...

ODYY - Odyssey Group International Files Patent On Novel Breath-Propelled Nasal Delivery Device

IRVINE, CA, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY ) (the "Company" or "Odyssey"), a medical technology company focused on developing unique, life-saving medical products, today announced the filing of a provisional patent on its novel nasal d...

ODYY - Odyssey Group International Begins Enrolling Subjects for Phase 1 Clinical Trial to Treat Concussion

IRVINE, CA, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY ) (the "Company" or "Odyssey"), a medical company focused on developing unique, life-saving medical products, today announced successful completion of their clinical trial site initiation vis...
ODYY - Odyssey Group International to Present at the HC Wainwright 23rd Annual Global Investment Conference

IRVINE, CA, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY ) (the "Company" or "Odyssey"), a health related company focused on developing unique, medical products including a treatment for concussion, today announced that its management team will giv...

ODYY - Odyssey Group International Approved to Start Human Trial to Treat Concussion        

IRVINE, CA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY ) (the "Company" or "Odyssey"), a company focused on developing unique, life-saving medical products, today announced its approval to begin Phase 1 human clinical trials for drug candidate PR...

ODYY - Odyssey Group International Completes Final Drug-Device Combination Product in Preparation for Clinical Trial Launch

IRVINE, CA, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTC: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique medical products, today announced the successful completion of their novel drug-device c...
Previous 10 Next 10